However, during end-stage liver cirrhosis in mice, hepatic Nrf2 is inhibited as a result of activation of the Ire1a-Xbp1 arm of the UPR, which promotes disease [24,40]. This evidence concerns the gene NFE2L2 and cirrhosis of liver.